Pharmafile Logo
Pharmafocus logo
Advanced Search
aedes_aegypti_during_blood_meal

‘Super malaria’ sweeps South East Asia

September 25, 2017
Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …

News
shutterstock_235920349

Indivior reaches settlement with Mylan over patent dispute

September 25, 2017
Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone

Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …

News
jj_2johnson_and_johnson

FDA rejects J&J’s treatment for rheumatoid arthritis

September 25, 2017
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab

Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …

News
alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017
Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

News
fda_building_web

19 deaths from liver drug causes Intercept shares to tumble

September 22, 2017
Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …

News

NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation

September 22, 2017
Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …

News

New therapy offers triple threat to HIV virus

September 22, 2017
Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

News
crack_cocaine

Weight loss drugs could be used to treat cocaine addiction

September 21, 2017
Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …

News
andrew_witty_gsk

Witty, Ex-CEO of GSK, keeps busy with two new roles in two days

September 21, 2017
Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …

News
gp_commissioning_patient

Report finds variation in quality of care in GP practices across England

September 21, 2017
Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …

News

Merck and Pfizer’s joint skin cancer drug gets EU approval

September 21, 2017
Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer

Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …

News
Bayer image

Bayer pulls plug on sterilisation device after numerous complaints

September 21, 2017
Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …

News
novartis_side_building

Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis

September 20, 2017
Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …

News
bill_gates_-_world_economic_forum_annual_meeting_davos_2008_number2

Gates Foundation invest in Immunocore, warning of infectious disease threat

September 20, 2017
Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …

News
world_health_organization

Antibiotic development is inadequate to meet global resistance threat, WHO warns

September 20, 2017
Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …

News

BMS’ Opdivo to finally be made available to lung cancer patients in the UK

September 20, 2017
Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical

It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …

News
gsk_hq_close

GSK gets FDA approval for key triple therapy inhaler

September 20, 2017
Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical

The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.

News
acute_leukemia-all

Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint

September 19, 2017
Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical

Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …

News
janssen_latest_logo_on_sign_closer

Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab

September 19, 2017
Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals

Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026